MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 05-16-2026
Venus Concept DPO Ratio 2011-2026 | VERO
Annual DPO Ratio Venus Concept
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 138 | 129 | 89.6 | 85.3 | 86.7 | 102 | 112 | 61.4 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 138 | 61.4 | 100 |
Quarterly DPO Ratio Venus Concept
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119 | 96.3 | 129 | - | 128 | 144 | 132 | - | 129 | 123 | 104 | - | 57.4 | 49.8 | 51.2 | - | 65.6 | 75.9 | 77.2 | - | 80.4 | 113 | 137 | - | 68.8 | 59.5 | 56.1 | - | 133 | 138 | 83.9 | - | 75.4 | 53.5 | 55.9 | - | 33 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 144 | 33 | 91.8 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
54.7 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
33.2 | $ 11.53 | -1.45 % | $ 326 M | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
73.8 | $ 8.23 | -0.06 % | $ 1.24 B | USA |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
116 | $ 4.35 | -1.14 % | $ 163 M |  France |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
LivaNova PLC
LIVN
|
68 | $ 74.1 | 0.62 % | $ 4.04 B |  Britain |
 |
LENSAR
LNSR
|
146 | $ 6.04 | 1.51 % | $ 72.2 M | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
1.01 K | $ 2.3 | -2.54 % | $ 50.7 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
107 | $ 0.46 | 0.11 % | $ 28.6 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 18.56 | 0.71 % | $ 435 M | USA |
 |
Delcath Systems
DCTH
|
56 | $ 11.35 | -0.87 % | $ 407 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Profound Medical Corp.
PROF
|
112 | $ 6.94 | -0.43 % | $ 210 M | Canada |
 |
IRIDEX Corporation
IRIX
|
29.4 | $ 1.03 | 2.48 % | $ 17.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
MiMedx Group
MDXG
|
54.8 | $ 3.64 | 0.69 % | $ 538 M | USA |
 |
Pulmonx Corporation
LUNG
|
60.4 | $ 1.58 | 2.6 % | $ 64.3 M | USA |
 |
Electromed
ELMD
|
47.8 | $ 38.32 | -0.69 % | $ 324 M | USA |
 |
Myomo
MYO
|
34.8 | $ 1.07 | 12.66 % | $ 44.8 M | USA |
 |
Butterfly Network
BFLY
|
34.1 | $ 4.41 | -1.45 % | $ 1.09 B | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
Sintx Technologies
SINT
|
223 | $ 2.42 | 5.22 % | $ 6.71 M | USA |
 |
Orthofix Medical
OFIX
|
76.3 | $ 10.71 | 2.88 % | $ 424 M |  Curacao |
 |
GBS
GBS
|
319 | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
33.1 | $ 85.2 | 0.73 % | $ 11.5 B | USA |
 |
Insulet Corporation
PODD
|
22.5 | $ 154.1 | -1.78 % | $ 10.8 B | USA |
 |
TransMedics Group
TMDX
|
15.5 | $ 68.37 | -0.7 % | $ 2.32 B | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 37.35 | 0.86 % | $ 1.16 B | USA |
 |
Inspire Medical Systems
INSP
|
103 | $ 43.16 | -3.64 % | $ 1.27 B | USA |
 |
Integer Holdings Corporation
ITGR
|
28.9 | $ 89.73 | -0.28 % | $ 3.12 B | USA |
 |
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
58.1 | $ 84.71 | 1.81 % | $ 49.5 B | USA |